| Outcome Measures: |
Primary: Acceptability of an oral solution of glibenclamide (Hedonic visual scale), Hedonic visual scale, 2 months after the change from pills to oral solution.|Acceptability of an oral solution of glibenclamide (Hedonic visual scale), Hedonic visual scale, 3 months after the change from pills to oral solution. | Secondary: Tolerance of an oral solution of glibenclamide (Self administrated questionnaries), Self administrated questionnaries, liver and renal biology, 2 months after the change from pills to oral solution.|Tolerance of an oral solution of glibenclamide (Self administrated questionnaries), Self administrated questionnaries, liver and renal biology, 3 months after the change from pills to oral solution.|Recording pharmaceutical data on pills and oral solution of glibenclamide (Blood drug dosage), Blood drug dosage, At inclusion|Recording pharmaceutical data on pills and oral solution of glibenclamide (Blood drug dosage), Blood drug dosage, 2 months after the switch from pills to oral solution|No alteration in metabolic control of the disease, HbA1C at month 3, fructosamine at month 2 and 3, self record of hypoglycaemia during month 1, 2 and 3, glycemia before and after meals during 2 consecutive days at introduction of oral solution and during 2 meals at month 2 and month 3, During the first month of administration|No alteration in metabolic control of the disease, HbA1C at month 3, fructosamine at month 2 and 3, self record of hypoglycaemia during month 1, 2 and 3, glycemia before and after meals during 2 consecutive days at introduction of oral solution and during 2 meals at month 2 and month 3, 2 months after the change from pills to oral solution|No alteration in metabolic control of the disease, HbA1C at month 3, fructosamine at month 2 and 3, self record of hypoglycaemia during month 1, 2 and 3, glycemia before and after meals during 2 consecutive days at introduction of oral solution and during 2 meals at month 2 and month 3, 3 months after the change from pills to oral solution
|